Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Lee Schwartzberg MD, FACP
Lee S. Schwartzberg MD, FACP Advisory Board
Sarah Goldberg MD, MPH
Sarah B. Goldberg MD, MPH Advisory Board
Annette Hasenburg Prof., Dr, med
Annette Hasenburg Prof., Dr, med Advisory Board
See All Experts
Published in Oncology

Journal Scan / Research · November 19, 2022

Beneficial Effects of Mifepristone in Patients With Breast Cancer Selected by the Progesterone Receptor Isoform Ratio

Clinical Cancer Research

 

 Save  Recommend
 Share

Additional Info

Clinical Cancer Research
Beneficial effects of mifepristone treatment in breast cancer patients selected by the progesterone receptor isoform ratio: Results from the MIPRA trial
Clin. Cancer Res 2022 Oct 21;[EPub Ahead of Print], A Elía, L Saldain, SI Vanzulli, LA Helguero, CA Lamb, V Fabris, G Pataccini, P Martínez-Vazquez, J Burruchaga, I Caillet-Bois, E Spengler, G Acosta Haab, M Liguori, A Castets, S Lovisi, MF Abascal, V Novaro, J Sánchez, J Muñoz, JM Belizán, MC Abba, H Gass, P Rojas, C Lanari

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated